Mammalian target of rapamycin (mTOR) as a target in human breast cancer cells that have acquired resistance to aromatase inhibitor letrozole

被引：0

作者：

Sabnis, Gauri J. ^{[1
]}

Jelovac, Danijela ^{[1
]}

Long, Brian J. ^{[1
]}

Schayowitz, Adam ^{[1
]}

Belosay, Aashvini ^{[1
]}

Brodie, Angela M. H. ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

来源：

CANCER RESEARCH | 2006年 / 66卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2316

引用

页数：2

共 50 条

[1] Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer
Chollet, Philippe
Abrial, Catherine
Tacca, Olivier
Mouret-Reynier, Marie-Ange
Leheurteur, Marianne
Durando, Xavier
Cure, Herve
CLINICAL BREAST CANCER, 2006, 7 (04) : 336 - 338
[2] The ATP-competitive mammalian target of rapamycin (mTOR) inhibitors suppress proliferation and induce apoptosis in the acquired rapamycin resistant breast cancer cells
Wu Tzung-Ju
Tsang Chi-Kwan
Zhang Yan-Jie
Steven, Zheng X. F.
CLINICAL CANCER RESEARCH, 2012, 18 (10)
[3] Mammalian target of rapamycin (mTOR) as a target for cancer therapeutic development.
Dancey, J
CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3823S - 3824S
[4] Activation of mammalian target of rapamycin (mTor) in human restenosis
Morehead, Preston N.
Kong, Lingwei
Kang, Jing
Solis, Maurice M.
Nakayama, Don K.
Wang, Zhonbgiao
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S159 - S159
[5] The Role of Mammalian Target of Rapamycin (mTOR) Inhibition in the Treatment of Advanced Breast Cancer
Michael Gnant
Current Oncology Reports, 2013, 15 : 14 - 23
[6] The Role of Mammalian Target of Rapamycin (mTOR) Inhibition in the Treatment of Advanced Breast Cancer
Gnant, Michael
CURRENT ONCOLOGY REPORTS, 2013, 15 (01) : 14 - 23
[7] New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
Hetty Carraway
Manuel Hidalgo
Breast Cancer Research, 6
[8] New targets for therapy in breast cancer - Mammalian target of rapamycin (mTOR) antagonists
Carraway, H
Hidalgo, M
BREAST CANCER RESEARCH, 2004, 6 (05) : 219 - 224
[9] Controversies in breast cancer: The mammalian target of rapamycin as a target for breast cancer therapy
Di Cosimo S.
Breast Cancer Research, 11 (Suppl 3)
[10] Effects of rapamycin on the mechanistic target of rapamycin (mTOR) pathway and telomerase in breast cancer cells
Gopalakrishnan, Kalpana
Venkatesan, Shriram
Low, Esther Su Hui
Hande, M. Prakash
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2018, 836 : 103 - 113

← 1 2 3 4 5 →